Antiarrhythmic therapy

New additions and future expectations

W. B. Ross, Syed M. Mohiuddin

Research output: Contribution to journalArticle

Abstract

The major promise of aprindine, which is under investigation in the United States, is as an oral agent for maintenance therapy of arrhythmias. It is effective in controlling incessant ventricular tachycardia. Since tocainide does not undergo extensive 'first-pass' metabolism by the liver, it becomes an effective oral agent in treating drug-refractory ventricular arrhythmias. Side effects are mild or moderate, with CNS involvement being the most common.

Original languageEnglish
Pages (from-to)30-35
Number of pages6
JournalGeriatrics
Volume38
Issue number1
StatePublished - 1983

Fingerprint

Cardiac Arrhythmias
Aprindine
Tocainide
Ventricular Tachycardia
Liver
Therapeutics
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Geriatrics and Gerontology

Cite this

Antiarrhythmic therapy : New additions and future expectations. / Ross, W. B.; Mohiuddin, Syed M.

In: Geriatrics, Vol. 38, No. 1, 1983, p. 30-35.

Research output: Contribution to journalArticle

@article{126056a5dd354ca0a6013ffd9e8bcc29,
title = "Antiarrhythmic therapy: New additions and future expectations",
abstract = "The major promise of aprindine, which is under investigation in the United States, is as an oral agent for maintenance therapy of arrhythmias. It is effective in controlling incessant ventricular tachycardia. Since tocainide does not undergo extensive 'first-pass' metabolism by the liver, it becomes an effective oral agent in treating drug-refractory ventricular arrhythmias. Side effects are mild or moderate, with CNS involvement being the most common.",
author = "Ross, {W. B.} and Mohiuddin, {Syed M.}",
year = "1983",
language = "English",
volume = "38",
pages = "30--35",
journal = "Geriatrics",
issn = "0016-867X",
publisher = "Advanstar Communications",
number = "1",

}

TY - JOUR

T1 - Antiarrhythmic therapy

T2 - New additions and future expectations

AU - Ross, W. B.

AU - Mohiuddin, Syed M.

PY - 1983

Y1 - 1983

N2 - The major promise of aprindine, which is under investigation in the United States, is as an oral agent for maintenance therapy of arrhythmias. It is effective in controlling incessant ventricular tachycardia. Since tocainide does not undergo extensive 'first-pass' metabolism by the liver, it becomes an effective oral agent in treating drug-refractory ventricular arrhythmias. Side effects are mild or moderate, with CNS involvement being the most common.

AB - The major promise of aprindine, which is under investigation in the United States, is as an oral agent for maintenance therapy of arrhythmias. It is effective in controlling incessant ventricular tachycardia. Since tocainide does not undergo extensive 'first-pass' metabolism by the liver, it becomes an effective oral agent in treating drug-refractory ventricular arrhythmias. Side effects are mild or moderate, with CNS involvement being the most common.

UR - http://www.scopus.com/inward/record.url?scp=0020674209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020674209&partnerID=8YFLogxK

M3 - Article

VL - 38

SP - 30

EP - 35

JO - Geriatrics

JF - Geriatrics

SN - 0016-867X

IS - 1

ER -